| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
|
N Engl J Med
|
2011
|
10.79
|
|
2
|
Changes in the burden of malaria in sub-Saharan Africa.
|
Lancet Infect Dis
|
2010
|
7.42
|
|
3
|
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
|
N Engl J Med
|
2012
|
6.64
|
|
4
|
Use of clinical algorithms for diagnosing malaria.
|
Trop Med Int Health
|
2002
|
5.77
|
|
5
|
A research agenda to underpin malaria eradication.
|
PLoS Med
|
2011
|
5.34
|
|
6
|
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.
|
Lancet
|
2007
|
5.11
|
|
7
|
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
|
Lancet
|
2009
|
4.84
|
|
8
|
Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
|
Lancet
|
2005
|
3.94
|
|
9
|
Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.
|
Lancet
|
2006
|
3.90
|
|
10
|
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
|
BMJ
|
2005
|
3.87
|
|
11
|
Identification of hot spots of malaria transmission for targeted malaria control.
|
J Infect Dis
|
2010
|
3.86
|
|
12
|
From malaria control to eradication: The WHO perspective.
|
Trop Med Int Health
|
2009
|
3.85
|
|
13
|
Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis.
|
PLoS One
|
2010
|
2.90
|
|
14
|
A call to action for the new decade of vaccines.
|
Lancet
|
2011
|
2.72
|
|
15
|
Epidemiology of malaria in the forest-savanna transitional zone of Ghana.
|
Malar J
|
2009
|
2.67
|
|
16
|
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
|
Lancet Infect Dis
|
2011
|
2.54
|
|
17
|
Changing pattern of malaria in Bissau, Guinea Bissau.
|
Trop Med Int Health
|
2008
|
2.54
|
|
18
|
Pneumococcal vaccination in developing countries.
|
Lancet
|
2006
|
2.45
|
|
19
|
Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission settings in the East African highlands.
|
Malar J
|
2008
|
2.37
|
|
20
|
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
|
Lancet
|
2009
|
2.34
|
|
21
|
A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children.
|
PLoS One
|
2008
|
2.24
|
|
22
|
Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia.
|
Pediatr Infect Dis J
|
2006
|
2.24
|
|
23
|
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.
|
PLoS One
|
2008
|
2.19
|
|
24
|
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.
|
PLoS One
|
2009
|
2.18
|
|
25
|
The changing and dynamic epidemiology of meningococcal disease.
|
Vaccine
|
2011
|
2.05
|
|
26
|
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
|
PLoS Med
|
2011
|
2.05
|
|
27
|
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial.
|
PLoS One
|
2010
|
2.03
|
|
28
|
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
|
Lancet
|
2006
|
2.00
|
|
29
|
Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
|
PLoS One
|
2009
|
1.73
|
|
30
|
Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed?
|
Malar J
|
2007
|
1.72
|
|
31
|
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
|
PLoS One
|
2008
|
1.68
|
|
32
|
Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana.
|
Malar J
|
2010
|
1.65
|
|
33
|
Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
|
PLoS One
|
2009
|
1.65
|
|
34
|
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.
|
PLoS Clin Trials
|
2006
|
1.65
|
|
35
|
Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics.
|
Malar J
|
2013
|
1.64
|
|
36
|
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial.
|
PLoS Med
|
2011
|
1.63
|
|
37
|
Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial.
|
PLoS Med
|
2011
|
1.61
|
|
38
|
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability.
|
Malar J
|
2010
|
1.58
|
|
39
|
The safety of artemisinins during pregnancy: a pressing question.
|
Malar J
|
2007
|
1.54
|
|
40
|
Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.
|
PLoS Med
|
2011
|
1.54
|
|
41
|
The contribution of social science research to malaria prevention and control.
|
Bull World Health Organ
|
2002
|
1.54
|
|
42
|
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
|
Pediatr Infect Dis J
|
2009
|
1.52
|
|
43
|
Effect of vaccines on bacterial meningitis worldwide.
|
Lancet
|
2012
|
1.50
|
|
44
|
The epidemiology of malaria in adults in a rural area of southern Mozambique.
|
Malar J
|
2007
|
1.49
|
|
45
|
Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana.
|
PLoS One
|
2008
|
1.48
|
|
46
|
Neglected tropical diseases and the Global Fund.
|
Lancet
|
2009
|
1.44
|
|
47
|
Editorial: 100 years of epidemic meningitis in West Africa - has anything changed?
|
Trop Med Int Health
|
2006
|
1.43
|
|
48
|
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine.
|
Malar J
|
2011
|
1.38
|
|
49
|
The age patterns of severe malaria syndromes in sub-Saharan Africa across a range of transmission intensities and seasonality settings.
|
Malar J
|
2010
|
1.38
|
|
50
|
Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial.
|
PLoS One
|
2009
|
1.38
|
|
51
|
Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.
|
Malar J
|
2008
|
1.37
|
|
52
|
The future of immunisation policy, implementation, and financing.
|
Lancet
|
2011
|
1.36
|
|
53
|
New malaria-control policies and child mortality in senegal: reaching millennium development goal 4.
|
J Infect Dis
|
2012
|
1.35
|
|
54
|
Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial.
|
Trop Med Int Health
|
2007
|
1.32
|
|
55
|
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.
|
PLoS One
|
2009
|
1.31
|
|
56
|
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
|
Vaccine
|
2012
|
1.30
|
|
57
|
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
|
PLoS One
|
2010
|
1.28
|
|
58
|
Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines.
|
Lancet
|
2011
|
1.27
|
|
59
|
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
|
J Infect Dis
|
2008
|
1.27
|
|
60
|
Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.
|
BMC Infect Dis
|
2013
|
1.27
|
|
61
|
Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci.
|
Trop Med Int Health
|
2007
|
1.26
|
|
62
|
Intermittent preventive antimalarial treatment in infants.
|
Clin Infect Dis
|
2007
|
1.23
|
|
63
|
The epidemiology of meningococcal disease in India.
|
Trop Med Int Health
|
2010
|
1.23
|
|
64
|
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.
|
J Infect Dis
|
2010
|
1.21
|
|
65
|
Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children.
|
Trop Med Int Health
|
2007
|
1.21
|
|
66
|
Malaria in school-age children in Africa: an increasingly important challenge.
|
Trop Med Int Health
|
2014
|
1.19
|
|
67
|
Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.
|
PLoS One
|
2010
|
1.19
|
|
68
|
Effects of misclassification of causes of death on the power of a trial to assess the efficacy of a pneumococcal conjugate vaccine in The Gambia.
|
Int J Epidemiol
|
2003
|
1.17
|
|
69
|
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability.
|
PLoS One
|
2011
|
1.17
|
|
70
|
Malaria-attributed death rates in India.
|
Lancet
|
2011
|
1.16
|
|
71
|
The development of Lapdap, an affordable new treatment for malaria.
|
Lancet Infect Dis
|
2003
|
1.16
|
|
72
|
Influence of wasting and stunting at the onset of the rainy season on subsequent malaria morbidity among rural preschool children in Senegal.
|
Am J Trop Med Hyg
|
2009
|
1.14
|
|
73
|
Treatment uptake by individuals infected with Plasmodium falciparum in rural Gambia, West Africa.
|
Bull World Health Organ
|
2002
|
1.11
|
|
74
|
Malaria in pregnancy in an area of stable and intense transmission: is it asymptomatic?
|
Trop Med Int Health
|
2008
|
1.11
|
|
75
|
A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children.
|
PLoS One
|
2010
|
1.11
|
|
76
|
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.
|
Malar J
|
2011
|
1.11
|
|
77
|
Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa.
|
Bull World Health Organ
|
2010
|
1.09
|
|
78
|
Hot spot or not: a comparison of spatial statistical methods to predict prospective malaria infections.
|
Malar J
|
2014
|
1.09
|
|
79
|
A global action plan for the prevention and control of pneumonia.
|
Bull World Health Organ
|
2008
|
1.05
|
|
80
|
Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants.
|
PLoS One
|
2008
|
1.04
|
|
81
|
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.
|
PLoS One
|
2010
|
1.04
|
|
82
|
Placental malaria and the risk of malaria in infants in a high malaria transmission area in ghana: a prospective cohort study.
|
J Infect Dis
|
2013
|
1.03
|
|
83
|
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
|
Malar J
|
2010
|
1.02
|
|
84
|
Interpreting vaccine efficacy.
|
Clin Infect Dis
|
2005
|
1.01
|
|
85
|
Comparison of all-cause and malaria-specific mortality from two West African countries with different malaria transmission patterns.
|
Malar J
|
2008
|
1.00
|
|
86
|
C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children.
|
Trop Med Int Health
|
2008
|
1.00
|
|
87
|
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
|
PLoS One
|
2011
|
0.99
|
|
88
|
Performance of the OptiMAL dipstick in the diagnosis of malaria infection in pregnancy.
|
Ther Clin Risk Manag
|
2008
|
0.98
|
|
89
|
Intermittent preventive treatment of malaria in children: a qualitative study of community perceptions and recommendations in Burkina Faso and Mali.
|
PLoS One
|
2012
|
0.97
|
|
90
|
Sampling methods to detect carriage of Neisseria meningitidis; literature review.
|
J Infect
|
2009
|
0.97
|
|
91
|
The safety of amodiaquine use in pregnant women.
|
Expert Opin Drug Saf
|
2007
|
0.95
|
|
92
|
The epidemiology of malaria among pregnant women attending antenatal clinics in an area with intense and highly seasonal malaria transmission in northern Ghana.
|
Trop Med Int Health
|
2009
|
0.95
|
|
93
|
Comparison of the therapeutic efficacy of chloroquine and sulphadoxine-pyremethamine in children and pregnant women.
|
Trop Med Int Health
|
2007
|
0.94
|
|
94
|
Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks.
|
Trans R Soc Trop Med Hyg
|
2006
|
0.94
|
|
95
|
Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children.
|
Malar J
|
2010
|
0.93
|
|
96
|
Malaria--a shadow over Africa.
|
Science
|
2002
|
0.93
|
|
97
|
A mathematical model of serotype replacement in pneumococcal carriage following vaccination.
|
J R Soc Interface
|
2013
|
0.93
|
|
98
|
A Gambian infant with fever and an unexpected blood film.
|
PLoS Med
|
2006
|
0.92
|
|
99
|
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants.
|
Trans R Soc Trop Med Hyg
|
2009
|
0.92
|
|
100
|
Trends in multiplicity of Plasmodium falciparum infections among asymptomatic residents in the middle belt of Ghana.
|
Malar J
|
2013
|
0.92
|
|
101
|
Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial.
|
PLoS One
|
2012
|
0.91
|
|
102
|
Comparison of the prevalence of common bacterial pathogens in the oropharynx and nasopharynx of gambian infants.
|
PLoS One
|
2013
|
0.91
|
|
103
|
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
|
Malar J
|
2015
|
0.91
|
|
104
|
A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.
|
PLoS One
|
2008
|
0.90
|
|
105
|
Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.
|
Am J Trop Med Hyg
|
2009
|
0.90
|
|
106
|
Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.
|
PLoS One
|
2011
|
0.90
|
|
107
|
Mefloquine safety and tolerability in pregnancy: a systematic literature review.
|
Malar J
|
2014
|
0.88
|
|
108
|
Malaria and bacteraemia in African children.
|
Lancet
|
2011
|
0.86
|
|
109
|
Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children.
|
Trop Med Int Health
|
2007
|
0.86
|
|
110
|
Folic acid treatment of Zambian children with moderate to severe malaria anemia.
|
Am J Trop Med Hyg
|
2006
|
0.86
|
|
111
|
Methods for identifying Neisseria meningitidis carriers: a multi-center study in the African meningitis belt.
|
PLoS One
|
2013
|
0.86
|
|
112
|
The need for targeted implementation research to improve coverage of basic vaccines and introduction of new vaccines.
|
Vaccine
|
2013
|
0.84
|
|
113
|
Pneumococcal meningitis epidemics in Africa.
|
Clin Infect Dis
|
2006
|
0.84
|
|
114
|
Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.
|
PLoS One
|
2010
|
0.84
|
|
115
|
Evaluating health workers' potential resistance to new interventions: a role for discrete choice experiments.
|
PLoS One
|
2011
|
0.84
|
|
116
|
Treating malaria in Africa.
|
BMJ
|
2004
|
0.84
|
|
117
|
Coverage, adherence and costs of intermittent preventive treatment of malaria in children employing different delivery strategies in Jasikan, Ghana.
|
PLoS One
|
2011
|
0.83
|
|
118
|
Prevention of the recurrence of anaemia in Gambian children following discharge from hospital.
|
PLoS One
|
2010
|
0.82
|
|
119
|
Are insecticide treated bednets failing?
|
Lancet Infect Dis
|
2012
|
0.81
|
|
120
|
Analysis of Preventive Interventions for Malaria: Exploring Partial and Complete Protection and Total and Primary Intervention Effects.
|
Am J Epidemiol
|
2015
|
0.80
|
|
121
|
Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
|
Am J Trop Med Hyg
|
2006
|
0.79
|
|
122
|
Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013.
|
Pediatr Infect Dis J
|
2015
|
0.79
|
|
123
|
Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine.
|
PLoS One
|
2012
|
0.79
|
|
124
|
A health facility based case-control study of effectiveness of insecticide treated nets: potential for selection bias due to pre-treatment with chloroquine.
|
Trop Med Int Health
|
2003
|
0.78
|
|
125
|
Global health and the Bill & Melinda Gates Foundation.
|
Lancet
|
2009
|
0.78
|
|
126
|
From genomics to surveillance, prevention and control: new challenges for the African meningitis belt.
|
Vaccine
|
2006
|
0.77
|
|
127
|
Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
|
PLoS One
|
2016
|
0.75
|
|
128
|
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
|
Emerg Infect Dis
|
2022
|
0.75
|
|
129
|
A new approach to the definition of seroconversion following vaccination in a population with high background antibody concentrations.
|
Vaccine
|
2007
|
0.75
|